Company Filing History:
2 out of 9 
2 out of 5 Years Active: 2020-2021
Title: Innovations by He Wang: A Pioneer in PEGylated Asparaginase
Introduction
He Wang, an accomplished inventor based in Changzhou, China, holds two patents that contribute significantly to the field of biomedicine. His work focuses on developing novel therapeutic applications, particularly in the area of anti-tumor drugs. He Wang's inventions demonstrate a commitment to enhancing cancer treatment methodologies through innovative scientific research.
Latest Patents
He Wang's most recent patent is titled "Site-specific polyethylene glycolylated (pegylated) asparaginase, preparation method therefor and use thereof." This patent describes a process in which polyethylene glycol (PEG) is coupled to the N-terminal amino of one or two subunits of L-asparaginase. Notably, the molecular weight of the PEG used in this application ranges from 30-40 KDa. The invention emphasizes the use of a branched PEG with an aldehyde group acting as an activating agent. The PEGylated asparaginase developed through this method reveals promising applications in the formulation of anti-tumor drugs, presenting a significant advancement in cancer therapeutics.
Career Highlights
Throughout his career, He Wang has contributed his expertise to prominent organizations, including the Zonhon Biopharma Institute, Inc. and the Gensun Institute of Biomedicine Co., Ltd. His involvement in these institutions has allowed him to refine his research skills and collaborate on several innovative projects aimed at advancing the biotechnology field.
Collaborations
In his professional journey, He Wang has collaborated with esteemed colleagues such as Bruce Yong Ma and Jun Wang. These collaborative efforts have facilitated knowledge sharing and have been instrumental in the progression of their joint research endeavors, enhancing the impact of their work on the industry.
Conclusion
He Wang's inventive contributions to the field of biomedicine, particularly through his development of PEGylated asparaginase, underscore his dedication to improving cancer treatment. With a foundation built on collaboration and innovation, his ongoing work promises to pave the way for more effective therapeutic solutions in oncology. His patents not only showcase his expertise but also highlight the significance of continual research and development in the realm of medical advancements.